SCHEMBL61467

SCHEMBL61467

CCN(CC)c1ccc(-c2ccc3ccccc3n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.56
RAB9A P51151 9/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
AR P10275 2/20 0.56
SMN1; SMN2 Q16637 8/20 0.55
KDM4E B2RXH2 7/20 0.55
ALDH1A1 P00352 6/20 0.55
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55
RELA Q04206 2/20 0.55
MAPT P10636 8/20 0.54
CYP3A4 P08684 3/20 0.54
TP53 P04637 2/20 0.54
PKM P14618 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
GMNN O75496 1/20 0.54
THPO P40225 1/20 0.54
BLM P54132 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8738496 0.88 NPC1 (0.50) NPC1RAB9AMEN1KMT2AAR
SCHEMBL7004637 0.86 NPC1 (0.47) NPC1RAB9AMEN1KMT2AAR
SCHEMBL15249330 0.83 AR (0.51) NPC1RAB9AMEN1KMT2AAR
SCHEMBL8739602 0.83 AR (0.58) NPC1RAB9AMEN1KMT2AAR
SCHEMBL16484521 0.81 RAB9A (0.61) NPC1RAB9AMEN1KMT2AAR
SCHEMBL29943655 0.81 RAB9A (0.61) NPC1RAB9AMEN1KMT2AAR
SCHEMBL62397 0.81 RAB9A (0.61) NPC1RAB9AMEN1KMT2AAR
SCHEMBL17430068 0.81 MAPT (0.55) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL12112870 0.80 RAB9A (0.80) NPC1RAB9AMEN1KMT2AAR
SCHEMBL5958621 0.80 ESR2 (0.55) MEN1KMT2AARKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640703-A1 HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY GE Healthcare UK Limited (GB) 2013-09-25 EP claimed
US-20130236395-A1 HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY GE HEALTHCARE LIMITED (GB) 2013-09-12 US claimed
WO-2012067863-A1 HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY GE HEALTHCARE LIMITED (GB) 2012-05-24 WO claimed
US-7118730-B2 Quinoline derivative as diagnostic probe for disease with tau protein accumulation BF RESEARCH INSTITUTE, INC. (JP) 2006-10-10 US claimed
EP-4257623-B1 PHOTOSENSITIVE POLYIMIDE RESIN COMPOSITION, RESIN FILM, AND ELECTRONIC DEVICE MITSUBISHI GAS CHEMICAL CO (JP) 2026-05-27 EP disclosed
CN-122029488-A Photosensitive coloring composition, cured product, partition wall, organic electroluminescent element, color filter, and image display device 三菱化学株式会社 2026-05-12 CN disclosed
US-12441842-B2 Polyimide resin, photosensitive resin composition, resin film, and electronic device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-10-14 US disclosed
CN-120029007-A Colored photosensitive resin composition, partition wall, organic electroluminescent element, image display device, and illumination 三菱化学株式会社 2025-05-23 CN disclosed
CN-112313579-B Photosensitive colored resin composition, cured product, image display device, and illumination 三菱化学株式会社 2025-05-13 CN disclosed
WO-2025084352-A1 PHOTOSENSITIVE COLORED COMPOSITION, CURED PRODUCT, PARTITION WALL, ORGANIC ELECTROLUMINESCENT ELEMENT, COLOR FILTER, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2025-04-24 WO disclosed
WO-2025084407-A1 PHOTOSENSITIVE COLORING COMPOSITION, CURED PRODUCT, PARTITION WALL, ORGANIC ELECTROLUMINESCENT ELEMENT, IMAGE DISPLAY DEVICE, AND PIGMENT DISPERSION LIQUID 三菱ケミカル株式会社 2025-04-24 WO disclosed
WO-2025075166-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, PARTITION WALL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2025-04-10 WO disclosed
US-20030172828-A1 Regenerative plate making and printing process, and plate making and printing apparatus MITSUBISHI HEAVY INDUSTRIES PRINTING & PACKAGING MACHINERY, LTD. (JP) 2003-09-18 US disclosed
EP-1287986-A1 METHOD AND DEVICE FOR REGENERATIVE PROCESSING AND PRINTING MITSUBISHI CHEMICAL CORPORATION (JP) 2003-03-05 EP disclosed
EP-0758097-B1 POLYMERIZABLE COMPOSITION FOR COLOR FILTER MITSUBISHI CHEM CORP (JP) 2002-08-21 EP disclosed
US-20020018962-A1 Photosensitive lithographic printing plate and method for making a printing plate MITSUBISHI CHEMICAL CORPORATION (JP) 2002-02-14 US disclosed
EP-1148387-A1 Photosensitive lithographic printing plate and method for making the printing plate MITSUBISHI CHEMICAL CORPORATION (JP) 2001-10-24 EP disclosed
US-6048653-A (METH)ACRYLATE COPOLYMER WITH ALICYCLIC(METH)ACRYLOYL GROUP ON THE SIDE CHAIN AND AN UNSATURATED DOUBLE BOND A PHOTOPOLYMERIZABLE INITIATOR AND COLORANT MITSUBISHI CHEMICAL CORPORATION (JP) 2000-04-11 US disclosed
US-5916713-A CONTAINING A (METH)ACRYLATE COPOLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 1999-06-29 US disclosed
EP-0758097-A1 POLYMERIZABLE COMPOSITION FOR COLOR FILTER MITSUBISHI CHEMICAL CORPORATION (JP) 1997-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130236395-A1 HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY MAPT, PSEN1, PSEN2 NPC1 127/4885RAB9A 1703/4885MEN1 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.